73.11.Z - Advertising agency activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,9 | 1 | 1,1 | 17,7 |
Gross profit (loss) | 1 | 1 | 1,3 | 29,2 |
EBITDA | 1,7 | 1,8 | 2,2 | 20,4 |
Short time liabilities | 1,5 | 2,1 | 1,5 | -29 |
Other operating costs | 0,1 | 0,1 | 0,1 | -18 |
Equity capital | 5,5 | 4,6 | 4,6 | -0,9 |
Operating profit (EBIT) | 1 | 1 | 1,3 | 33,8 |
Assets | 7,9 | 7,8 | 7,1 | -8,7 |
Net profit (loss) | 0,8 | 0,7 | 1 | 35,2 |
Cash | 2,2 | 0,9 | 1,8 | 98,8 |
Liabilities and provisions for liabilities | 2,4 | 3,2 | 2,6 | -20 |
Net income from sale | 18,5 | 20,3 | 23,9 | 17,7 |
Working assets | 6 | 5,5 | 4,1 | -24,4 |
Other income costs | 0,2 | 0,1 | 0,3 | 110,5 |
Depreciation | 0,7 | 0,9 | 0,9 | 4,7 |
% | % | % | p.p. | |
Profitability of capital | 13,7 | 15,4 | 21 | 5,6 |
Equity capital to total assets | 69,3 | 59,1 | 64,1 | 5 |
Gross profit margin | 5,5 | 4,9 | 5,4 | 0,5 |
EBITDA Margin | 9,3 | 9,1 | 9,3 | 0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 38 | 23 | -15 |
Current financial liquidity indicator | 3.930525064468384 | 2.6039135456085205 | 2.7742652893066406 | 0,2 |
Net dept to EBITDA | -1.2611238956451416 | -0.490324467420578 | -0.8097110986709595 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane